by admin | Aug 29, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
by Michael Gibney – PharmaVoice – The first cell therapy approved by the FDA, Dendreon’s Provenge for prostate cancer, had a bumpy start on the market in 2010, as the autologous treatment was logistically difficult to manufacture and administer, and thus...
by admin | Aug 28, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Penn Medicine – The ability of a newly understood stem cell originating in skeletal muscle to turn into bone could hold the key to bone healing after catastrophic fractures. When bones break and there is extreme tissue loss—such as after a car accident or a...
by admin | Aug 27, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
by Quentin Johnson – dvidshub.net – FORT DETRICK, Md.– Scientists at the U.S. Army Medical Research Institute of Infectious Diseases have successfully created a novel 3D bioprinted vascular liver tissue model, marking a significant advancement in...
by admin | Aug 26, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Darren Incorvaia – Fierce Biotech – After the Department of Health and Human Services canceled about $500 million in funding for mRNA vaccine development, one senior agency leader has decided to call it quits. Alastair Thomson is resigning as chief data...
by admin | Aug 25, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By BMC – Part of SpringerNature – Trained immunity with human bone marrow mesenchymal stem cells (hBMSC) is a promising approach to liver regeneration. This study aimed to clarify the trained-hBMSC (T-hBMSC) in restoring tissue immuno-microenvironment in...
